Ernexa Therapeutics Inc.
ERNA | NASDAQ
$3.92
-$0.04 (-1.01%)
Sep 22, 2026, 1:02 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 487K | 47K | 47K | 17K | 51K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 86K | n/a | n/a | n/a | n/a | n/a | -60K | 95K | 602K | 66K | 120K | n/a | 50K | n/a | n/a | n/a | n/a | 123K | n/a | n/a | n/a |
Gross Profit | n/a | -86K | n/a | n/a | n/a | n/a | 1K | 547K | -48K | -555K | -49K | -69K | n/a | -50K | n/a | n/a | n/a | n/a | -123K | n/a | n/a | n/a |
Operating Income | -4.1M | -3.55M | -2.09M | -1.99M | -2.5M | -2.73M | -2.7M | -2.26M | -4.93M | -5.79M | -5.77M | -5.51M | -4.55M | -5.32M | -4.74M | -8.3M | -13.88M | -6.3M | -8.54M | -86.28M | -10.01M | -8.92M |
Interest Income | n/a | 44K | 47K | n/a | n/a | 5K | 249K | n/a | n/a | n/a | n/a | n/a | 24K | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -4.01M | -5.55M | -1.56M | -1.23M | -3.14M | -8.19M | -5.75M | -26.59M | -5.53M | -6.64M | -6.16M | -5.6M | -4.5M | -5.41M | -4.45M | -7.31M | -3.4M | -9.38M | -7.89M | -85.99M | -10.09M | -18.52M |
Net Income | -4.02M | -5.51M | -1.5M | -1.24M | -3.14M | -8.2M | -5.76M | -26.6M | -5.53M | -6.65M | -6.15M | -5.59M | -4.51M | -5.42M | -4.49M | -7.32M | -3.4M | -9.38M | -7.95M | -85.99M | -10.09M | -18.52M |
Selling & General & Admin | 1.31M | 1.63M | 1.42M | 958K | 1.37M | 1.42M | 1.54M | 3.38M | 3.9M | 3.77M | 4.51M | 3.98M | 2.59M | 3.59M | 3.7M | 3.34M | 5.43M | 4.51M | 4.16M | 4.23M | 4.58M | 1.62M |
Research & Development | 2.79M | 1.92M | 676K | 1.03M | 1.14M | 1.31M | 1.16M | 1M | 987K | 1.46M | 1.21M | 1.46M | 1.5M | 1.67M | 1.96M | 4.96M | 1.69M | 1.78M | 4.25M | 1.49M | 5.43M | 1.53M |
Other Expenses | n/a | -86K | n/a | n/a | n/a | n/a | n/a | -1.58M | n/a | n/a | n/a | n/a | 460K | n/a | -921K | n/a | 6.76M | n/a | n/a | 80.55M | n/a | 5.77M |
Operating Expenses | 4.1M | 3.46M | 2.09M | 1.99M | 2.5M | 2.73M | 2.7M | 2.81M | 4.88M | 5.23M | 5.72M | 5.44M | 4.55M | 5.27M | 4.74M | 8.3M | 13.88M | 6.3M | 8.41M | 86.28M | 10.01M | 8.92M |
Interest Expense | 55K | n/a | n/a | 31K | n/a | n/a | 3.48M | 1.69M | 797K | 786K | 388K | 114K | n/a | n/a | 6K | 10K | 13K | 1K | 18.03K | 20K | 22K | 14K |
Selling & Marketing Expenses | n/a | n/a | n/a | 6K | n/a | n/a | n/a | n/a | n/a | -541K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 3.55M | 2.09M | 1.99M | 2.5M | 2.73M | 2.7M | 2.75M | 4.98M | 5.83M | 5.78M | 5.56M | 4.55M | 5.32M | 4.74M | 8.3M | 13.88M | 6.3M | 8.54M | 86.28M | 10.01M | 8.92M |
Income Tax Expense | 8K | -40K | -62K | 6K | 3K | 8K | 11K | 12K | 3K | 4K | -4K | -8K | 4K | 5K | 40K | 5K | n/a | n/a | 64K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.18M | 792K | 314.16K | 329.04K | 207.16K | 2.13M | 2.06M | 216.4K | 216.4K | 216.4K | 216.4K | 216.4K | 212.12K | 205.08K | 176.06K | 117.64K | 117.6K | 107.24K | 104.08K | 101.08K | 84.9K | 55.6K |
Shares Outstanding (Diluted) | 1.18M | 792K | 314.16K | 329.04K | 207.16K | 2.13M | 2.06M | 216.4K | 216.4K | 216.4K | 216.4K | 216.4K | 212.12K | 205.08K | 176.06K | 117.64K | 117.61K | 107.25K | 104.08K | 101.08K | 84.9K | 55.6K |
EPS (Basic) | -3.40 | -6.95 | -4.75 | -3.75 | -15.25 | -3.75 | -10.50 | -123 | -25.50 | -30.75 | -28.50 | -25.75 | -21.25 | -26.50 | -25.50 | -62.25 | 60.25 | -116.25 | -81.25 | -851.25 | -118.75 | -318.50 |
EPS (Diluted) | -3.40 | -6.95 | -4.75 | -3.75 | -15.25 | -3.75 | -10.50 | -123 | -25.50 | -30.75 | -28.50 | -25.75 | -21.25 | -26.50 | -25.50 | -62.25 | 60.25 | -116 | -81.25 | -851.25 | -118.75 | -318.50 |
EBITDA | -4.1M | -5.46M | -6.81M | -1.19M | -3.08M | -8.13M | -2.2M | -24.46M | -4.15M | -5.32M | -5.15M | -4.97M | -4.03M | -5.35M | -4.36M | -7.18M | -3.23M | -9.24M | -7.75M | -85.84M | -9.95M | -18.41M |
EBIT | n/a | -5.55M | -6.88M | -1.2M | -3.14M | -8.19M | -2.27M | -24.91M | -4.73M | -5.86M | -5.63M | -5.49M | -4.09M | -5.41M | -4.44M | -7.3M | -3.39M | -9.37M | -7.87M | -85.97M | -10.06M | -18.51M |
Depreciation & Amortization | n/a | 86K | 69K | 17K | 55K | 69K | 68K | 451K | 578K | 541K | 481K | 517K | 63K | 62K | 86K | 121K | 152K | 138K | 123.4K | 124K | 117K | 95K |
Add to Watchlist
Select watchlists to add or remove ERNA